67 results
Page 4 of 4
8-K
EX-99.1
6kga7 hzrzc02d
11 May 20
Sutro Biopharma Reports First Quarter 2020 Financial Results
4:27pm
424B5
mlq0umr0 3i
11 May 20
Prospectus supplement for primary offering
4:12pm
8-K
EX-99.1
7sr345ww5l4k228za
27 Apr 20
Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data for a Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer
8:00am
8-K
cqd02j26f4xrdmmfkao9
27 Apr 20
Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data for a Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer
8:00am
8-K
EX-99.2
1tcsdg0x1fd6qj
27 Apr 20
Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data for a Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer
8:00am